ArticleResearch square2023

Oral TGF-βR1 inhibitor Vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti-tumor immunity.

Sung Hee Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.